<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319711414867</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319711414867</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Diabetes and Insulin Resistance</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased Leisure-Time Physical Activity is Associated With Lower Prevalence of the Metabolic Syndrome in 64-Year Old Women With Impaired Glucose Tolerance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bergström</surname>
<given-names>Göran</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319711414867">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Behre</surname>
<given-names>CarlJohan</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319711414867">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Schmidt</surname>
<given-names>Caroline</given-names>
</name>
<degrees>CLS, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319711414867">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319711414867"/>
</contrib>
</contrib-group>
<aff id="aff1-0003319711414867"><label>1</label>The Wallenberg Laboratory at Sahlgrenska Center for Cardiovascular and Metabolic Research, The Sahlgrenska University Hospital, Gothenburg, Sweden</aff>
<author-notes>
<corresp id="corresp1-0003319711414867">Caroline Schmidt, Wallenberg Laboratory for Cardiovaascular Research, Sahlgrenska Academy at University of Gothenburg, S-413 45 Gothenburg, Sweden Email: <email>caroline.schmidt@wlab.gu.se</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>63</volume>
<issue>4</issue>
<fpage>297</fpage>
<lpage>301</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The metabolic syndrome (MetS) is characterized by a cluster of factors that confer an increased risk of cardiovascular morbidity as well as mortality. It is established that physical activity (PA) has a protective role in cardiovascular morbidity and mortality, mainly through favorable effects on traditional risk factors such as body mass and blood pressure. We assessed the prevalence of MetS in a population-based sample of 64-year-old women with impaired glucose tolerance (IGT) with respect to leisure-time PA (LTPA). The results showed an inverse linear association (<italic>P</italic> &lt; .05) between LTPA and MetS in this group. In conclusion, this study suggests that an increased PA level has an important role in preventing MetS in women with IGT.</p>
</abstract>
<kwd-group>
<kwd>metabolic syndrome</kwd>
<kwd>impaired glucose tolerance</kwd>
<kwd>leisure-time physical activity</kwd>
<kwd>women</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319711414867">
<title>Introduction</title>
<p>The metabolic syndrome (MetS) describes a cluster of atherosclerotic cardiovascular risk factors that increases the risk of diabetes as well as cardiovascular disease.<sup>
<xref ref-type="bibr" rid="bibr1-0003319711414867">1</xref>
</sup> Essential variables in MetS include visceral obesity, elevated blood pressure (BP), dyslipidemia with elevated triglycerides and low levels of high-density lipoprotein cholesterol (HDL-C), and raised fasting glucose.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711414867">2</xref><xref ref-type="bibr" rid="bibr3-0003319711414867"/>–<xref ref-type="bibr" rid="bibr4-0003319711414867">4</xref>
</sup> Metabolic syndrome poses a growing worldwide health problem due to the global epidemic of overweight and sedentary lifestyle.<sup>
<xref ref-type="bibr" rid="bibr5-0003319711414867">5</xref>
</sup>
</p>
<p>Impaired glucose tolerance (IGT) is characterized by increased levels of insulin both when fasting and after a glucose load and shows insulin resistance when investigated with glucose clamp techniques.<sup>
<xref ref-type="bibr" rid="bibr6-0003319711414867">6</xref>
</sup> Impaired glucose tolerance is a risk factor for the development of diabetes and also for cardiovascular disease and mortality in the general population.<sup>
<xref ref-type="bibr" rid="bibr7-0003319711414867">7</xref>,<xref ref-type="bibr" rid="bibr8-0003319711414867">8</xref>
</sup> Moreover, epidemiologic observations have shown that IGT is associated with the MetS according to the definition of the National Cholesterol Education Program (NCEP)<sup>
<xref ref-type="bibr" rid="bibr9-0003319711414867">9</xref>
</sup>, in about 50% of individuals.<sup>
<xref ref-type="bibr" rid="bibr10-0003319711414867">10</xref>
</sup>
</p>
<p>It is well known that physical activity (PA) has a protective role in cardiovascular morbidity and mortality, mainly through its favorable effects on conventional risk factors such as body mass and BP.<sup>
<xref ref-type="bibr" rid="bibr11-0003319711414867">11</xref>
</sup> Studies among different ethnic groups of women have shown inverse dose–response relationships between leisure-time PA (LTPA) and prevalence of the MetS.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711414867">2</xref>,<xref ref-type="bibr" rid="bibr12-0003319711414867">12</xref>
</sup>
</p>
<p>Impaired glucose tolerance has been found to be a risk factor for the development of type 2 diabetes and is also a crucial constituent of the MetS.<sup>
<xref ref-type="bibr" rid="bibr7-0003319711414867">7</xref>
</sup> Therefore, it would be of interest to investigate whether the increased levels of LTPA are associated with lower prevalence of MetS in individuals with diagnosed IGT, the aim being to identify a modifiable risk factor in patients with IGT.</p>
<p>There is a paucity of studies concerning the association between PA and MetS in this high-risk population of women.</p>
<p>Therefore, we performed this study to assess the prevalence of MetS in a population-based sample of 64-year-old women with IGT with respect to LTPA.</p>
</sec>
<sec id="section2-0003319711414867">
<title>Materials and Methods</title>
<sec id="section3-0003319711414867">
<title>Study Population</title>
<p>The Diabetes, Impaired Glucose Tolerance in Women and Atherosclerosis (DIWA) study was powered to examine subclinical atherosclerosis in the carotid and femoral arteries in a population sample of 64-year-old women living in the Gothenburg region. Briefly, 2602 women identified through the County Register were contacted and screened with a questionnaire.<sup>
<xref ref-type="bibr" rid="bibr13-0003319711414867">13</xref>
</sup> Diabetes, IGT, and normal glucose tolerance (NGT) were defined according to the World Health Organization classification.<sup>
<xref ref-type="bibr" rid="bibr14-0003319711414867">14</xref>
</sup> Diagnosis of IGT was based on 2 OGTTs fulfilling the IGT criteria. Women who had findings corresponding to IGT at the first Oral Glucose Tolerance Test (OGTT) and NGT at the second test were excluded from the present analysis.</p>
<p>Exclusion criteria were unwillingness to participate, recent cancer diagnosis, inflammatory disease, severe mental disorder, other severe illness, or drug addictions. Women who could not understand Swedish were also excluded.</p>
<p>All participants received both written and oral information before they gave their consent to take part in the survey. The protocol was approved by the Ethics Committee at Sahlgrenska University Hospital.</p>
</sec>
<sec id="section4-0003319711414867">
<title>Measurements</title>
<p>Previously described questionnaires were used to evaluate the history of previous and current disease, smoking habits, and alcohol consumption.<sup>
<xref ref-type="bibr" rid="bibr15-0003319711414867">15</xref>
</sup> Cigarette years was defined as the total number of years of smoking multiplied by the number of cigarettes smoked daily.</p>
<p>A self-administered questionnaire was used to assess the level of LTPA. The screening procedure has been described in detail previously.<sup>
<xref ref-type="bibr" rid="bibr16-0003319711414867">16</xref>
</sup> In brief, body weight, waist, and hip circumference were measured with the participants dressed in underwear. Heart rate and BP was measured twice after a 5-minute supine rest. Venous blood samples were drawn after a fasting period of at least 6 hours. Cholesterol and triglyceride levels were determined by enzymatic techniques (Thermo Fisher Scientific Oy, Vantaa, Finland). High-density lipoprotein cholesterol was determined after precipitation of apoB-containing lipoproteins and low-density lipoprotein cholesterol (LDL-C) was calculated as described by Friedewald et al.<sup>
<xref ref-type="bibr" rid="bibr17-0003319711414867">17</xref>
</sup>
</p>
<p>The study participants were divided into 3 groups according to their level of LTPA: (1) sedentary lifestyle: spends leisure time mostly reading, watching TV, or other sedentary activities; (2) moderate PA: walking, cycling, or other mild PA such as gardening, fishing, or bowling at least 4 h/week; and (3) hard/competitive PA: running, swimming, tennis, cross-country skiing, or other exercise that leads to sweating several days/week. This questionnaire has been evaluated in the Malmö Diet and Cancer study, Sweden, where significant associations for PA were shown with anthropometric and metabolic variables.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711414867">18</xref>
</sup>
</p>
</sec>
<sec id="section5-0003319711414867">
<title>Assessment of MetS According to the NCEP</title>
<p>For the diagnosis of MetS, NCEP requires that at least 3 of 5 clinical criteria are present:</p>
<p>(1) fasting plasma glucose ≥6.1 mmol/L (≥100 mg/dL); (2) BP ≥130/85 mm Hg (either value) or current antihypertensive medication; (3) triglyceride levels ≥1.7 mmol/L (≥150 mg/dL); (4) HDL-C levels &lt;1.0 mmol/L (&lt;40 mg/dL); and (5) waist circumference &gt;88 cm.<sup>
<xref ref-type="bibr" rid="bibr9-0003319711414867">9</xref>
</sup>
</p>
</sec>
<sec id="section6-0003319711414867">
<title>Statistics</title>
<p>All statistics were performed using SPSS 17.0 for Windows. Results are presented as mean ± SD unless otherwise indicated. A <italic>t</italic> test was used to compare continuous data. Comparison of nominal data was performed using Pearson chi-square test. The sedentary activity group was used as reference in the analyses. A <italic>P</italic> value of &lt;.05 (2-sided) was regarded significant. Cigarette years are presented as median and range.</p>
</sec>
</sec>
<sec id="section7-0003319711414867">
<title>Results</title>
<p>In this group of 64-year-old women with IGT (n = 207), 50% was diagnosed as having the MetS according to the NCEP criteria.<sup>
<xref ref-type="bibr" rid="bibr9-0003319711414867">9</xref>
</sup> Anthropometric and metabolic characteristics are summarized in <xref ref-type="table" rid="table1-0003319711414867">Table 1</xref>
. Body weight, body mass index (BMI), waist circumference, and waist–hip ratio were significantly increased in the individuals with MetS. In individuals with the MetS, the diastolic BP was significantly increased compared with those without MetS. Further, individuals with the MetS showed a dyslipidemic pattern with increased triglyceride levels and decreased HDL-C levels. Both glucose and insulin levels differed significantly between the groups, where the highest values were observed in the group with MetS. Further, individuals with the MetS showed increased levels of C-reactive protein (CRP) compared with individuals without MetS.</p>
<table-wrap id="table1-0003319711414867" position="float">
<label>Table 1.</label>
<caption>
<p>Anthropometric and Metabolic Characteristics of the Study Participants by the Metabolic Syndrome (MetS) According to the National Cholesterol Education Program (NCEP)
8
Criteria</p>
</caption>
<graphic alternate-form-of="table1-0003319711414867" xlink:href="10.1177_0003319711414867-table1.tif"/>
<table>
<thead>
<tr>
<th>Characteristics</th>
<th>MetS (n = 103)</th>
<th>No MetS (n = 104)</th>
<th align="center">
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Weight, kg</td>
<td>81.5 ± 13.8</td>
<td>68.0 ± 10.5</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Body mass index, kg/m<sup>2</sup>
</td>
<td>30.5 ± 4.7</td>
<td>25.4 ± 3.7</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Waist circumference, cm</td>
<td>99 ± 11</td>
<td>86 ± 9</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Waist–hip ratio</td>
<td>0.90 ± 0.06</td>
<td>0.85 ± 0.09</td>
<td>&lt;.001</td>
</tr>
<tr>
<td colspan="4">Blood pressure, mm Hg</td>
</tr>
<tr>
<td> Systolic</td>
<td>158 ± 19</td>
<td>153 ± 20</td>
<td>.08</td>
</tr>
<tr>
<td> Diastolic</td>
<td>88 ± 8</td>
<td>85 ± 9</td>
<td>&lt;.05</td>
</tr>
<tr>
<td> Heart rate, bpm</td>
<td>72 ± 10</td>
<td>71 ± 9</td>
<td>.90</td>
</tr>
<tr>
<td> Plasma glucose, mmol/L</td>
<td>6.0 ± 0.8</td>
<td>5.5 ± 0.6</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Plasma insulin, pmol/L</td>
<td>74.7 ± 39.4</td>
<td>35.2 ± 17.6</td>
<td>&lt;.001</td>
</tr>
<tr>
<td colspan="4">Serum cholesterol, mmol/L</td>
</tr>
<tr>
<td> Total</td>
<td>6.08 ± 1.00</td>
<td>5.83 ± 1.06</td>
<td>.09</td>
</tr>
<tr>
<td> Low-density lipoprotein (LDL)</td>
<td>3.78 ± 0.92</td>
<td>3.55 ± 0.90</td>
<td>.08</td>
</tr>
<tr>
<td> High-density lipoprotein (HDL)</td>
<td>1.44 ± 0.37</td>
<td>1.79 ± 0.39</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> Triglycerides<sup>
<xref ref-type="table-fn" rid="table-fn1-0003319711414867">
a
</xref>
</sup>
</td>
<td>1.79 ± 0.78</td>
<td>1.03 ± 0.38</td>
<td>&lt;.001</td>
</tr>
<tr>
<td colspan="4">Apolipoproteins, g/L</td>
</tr>
<tr>
<td> ApoB</td>
<td>1.27 ± 0.25</td>
<td>1.06 ± 0.23</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> ApoA-I</td>
<td>1.53 ± 0.24</td>
<td>1.63 ± 0.27</td>
<td>&lt;.01</td>
</tr>
<tr>
<td> ApoB/apoA-I ratio</td>
<td>0.85 ± 0.20</td>
<td>0.66 ± 0.16</td>
<td>&lt;.001</td>
</tr>
<tr>
<td> C-reactive protein, mg/L</td>
<td>3.3 ± 4.0</td>
<td>1.8 ± 2.6</td>
<td>&lt;.01</td>
</tr>
<tr>
<td> Active smoker, n (%)</td>
<td>12 (12)</td>
<td>28 (27)</td>
<td>&lt;.01<sup>
<xref ref-type="table-fn" rid="table-fn2-0003319711414867">
b
</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319711414867">
<p>
<sup>a</sup> Geometric mean.</p>
</fn>
<fn id="table-fn2-0003319711414867">
<p>
<sup>b</sup> Chi-square test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section8-0003319711414867">
<title>Physical Activity and the MetS</title>
<p>
<xref ref-type="fig" rid="fig1-0003319711414867">Figure 1</xref>
shows a significant trend (<italic>P</italic> &lt; .05) toward fewer individuals with MetS by increased LTPA. Metabolic syndrome was more common in the group that spends their leisure time with sedentary activities and was less common in the group that performed hard/competitive PAs during their leisure time.</p>
<fig id="fig1-0003319711414867" position="float">
<label>Figure 1.</label>
<caption>
<p>Bar chart illustrating the distribution of the metabolic syndrome (MetS) according to the National Cholesterol Education Program (NCEP) criteria in the leisure-time physical activity (LTPA) groups (n = 207). Linear to linear association <italic>P</italic> &lt; .05, Pearson chi-square.</p>
</caption>
<graphic xlink:href="10.1177_0003319711414867-fig1.tif"/>
</fig>
<p>A significant difference (<italic>P</italic> &lt; .05) in prevalence of MetS was observed between the groups who enjoyed a sedentary lifestyle compared to the group that performed regular/competitive levels of LTPA.</p>
<p>A significant negative correlation between LTPA and waist circumference and triglycerides (<italic>r</italic>
<sub>s</sub> = −0.157, <italic>P</italic> = .027 and <italic>r</italic>
<sub>s</sub> = −0.159, <italic>P</italic> = .026) was observed.</p>
</sec>
<sec id="section9-0003319711414867">
<title>Prevalence of the Single Parameter Contained in the MetS</title>
<p>Increased BP (93%) presented the highest prevalence followed by increased waist circumference (61%) and increased triglyceride levels (35%).</p>
</sec>
</sec>
<sec id="section10-0003319711414867">
<title>Discussion</title>
<p>This cross-sectional study of 64-year-old women with IGT living in the Gothenburg region showed a high prevalence of MetS when using the NCEP criteria.<sup>
<xref ref-type="bibr" rid="bibr8-0003319711414867">8</xref>
</sup> An inverse association between LTPA and MetS was observed, with higher prevalence of MetS in the sedentary group and lowest prevalence in the group that performed hard/competitive PA during their leisure time.</p>
<p>In a population-based study by Halldin et al, a similar association between PA and MetS was observed in 60-year-old participants. They included both sexes, but the study was not restricted to participants with IGT—a high-risk population.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711414867">2</xref>
</sup> Our study showed that 83% of the women with IGT performed at least light PAs during their leisure time. This is in accordance with the study by Halldin and coworkers in which 72% to 83% of the participants reported a light-to-moderate PA.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711414867">2</xref>
</sup> They also observed that the 3 most prevalent MetS components were BP, and waist circumference together with increased triglyceride levels. This is in accordance with our present study as well as what we have earlier reported from 58-year-old men in the in the Atherosclerosis and Insulin Resistance study (AIR) study.<sup>
<xref ref-type="bibr" rid="bibr19-0003319711414867">19</xref>
</sup>
</p>
<p>In the present study, we observed that waist circumference, a recognized marker for visceral fat, was significantly higher in the MetS group. This is important, given the impact of visceral fat on the typical dyslipidemic pattern seen in the MetS, with elevated triglyceride levels and decreased levels of HDL-C.<sup>
<xref ref-type="bibr" rid="bibr20-0003319711414867">20</xref>
</sup> Further, individuals with MetS are characterized by upper body obesity which in turn, is associated with increased CRP levels. This association is suggested to depend on the synthesis of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and leptin from the adipose tissue.<sup>
<xref ref-type="bibr" rid="bibr21-0003319711414867">21</xref>,<xref ref-type="bibr" rid="bibr22-0003319711414867">22</xref>
</sup> Increased CRP levels in MetS have been previously observed in the West of Scotland Coronary Prevention Study (WOSCOPS) study<sup>
<xref ref-type="bibr" rid="bibr23-0003319711414867">23</xref>
</sup> and were associated with a higher cardiovascular risk. C-reactive protein has also emerged as an independent risk factor in a large prospective study of clinically healthy women with or without MetS.</p>
<p>There are methodological aspects to this study which have to be considered. First, we used the NCEP criteria for assessing the prevalence of MetS. However, the prevalence of MetS differs significantly according to which definition is used.<sup>
<xref ref-type="bibr" rid="bibr24-0003319711414867">24</xref>
</sup>
</p>
<p>Second, the questionnaire used in this study relies on self-reported LTPA. However, there is no gold-standard method to assess LTPA. The format of the questionnaire used in our study has previously been demonstrated to show significant associations with both anthropometric factors and metabolic components.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711414867">18</xref>
</sup>
</p>
<p>Third, this study had a cross-sectional design and we cannot draw any conclusions about causality. However, the advantage of a cross-sectional design is that the all variables are assessed at the same time and therefore bias owing to variations between independent and dependent variables within the same individual is reduced.</p>
<p>Moreover, we have focused on a cohort of IGT women with the weakness that the results cannot be extended beyond the studied cohort. Nevertheless, focusing on a single cohort has the advantage that it rules out variation in age, sex, and ethnicity. Further, IGT is a clinically silent but important risk factor for type 2 diabetes. We only included women, and diabetes in women is associated with a higher relative risk of cardiovascular disease than for men.<sup>
<xref ref-type="bibr" rid="bibr25-0003319711414867">25</xref>
</sup>
</p>
<p>Further, the present study was fairly small. Therefore, a larger study will be needed to validate the relationship between LTPA and MetS in patients with IGT and to adjust for covariates.</p>
<p>In conclusion, this study demonstrated a high prevalence of MetS among 64-year-old women with IGT. The occurrence of MetS was less common in the group that performed hard/competitive PA compared with the group that was more sedentary. This study suggests that increased levels of PA have an important role in preventing MetS in women with IGT.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319711414867">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319711414867">
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or authorship of this article: Grants from the Swedish Heart-Lung Foundation, the Swedish Medical Research Council (12270, 10880) and Astra Zeneca, Mölndal, Sweden supported this work.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319711414867">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Watts</surname>
<given-names>GF</given-names>
</name>
</person-group>. <article-title>Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies</article-title>. <source>Expert Opin Pharmacother</source>. <year>2011</year>;<volume>12</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr2-0003319711414867">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halldin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosell</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Faire</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Hellenius</surname>
<given-names>ML</given-names>
</name>
</person-group>. <article-title>The metabolic syndrome: prevalence and association to leisure-time and work related physical activity in 60-year-old men and women</article-title>. <source>Nutr Cardiovasc Dis</source>. <year>2007</year>;<volume>17</volume>(<issue>5</issue>):<fpage>349</fpage>–<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr3-0003319711414867">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sisson</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Camhi</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>TS</given-names>
</name>
<etal/>
</person-group>. <article-title>Leisure time sedentary behavior, occupational/domestic physical activity and metabolic syndrome in US men and women</article-title>. <source>Metab Syndr Relat Disord</source>. <year>2009</year>;<volume>7</volume>(<issue>6</issue>):<fpage>529</fpage>–<lpage>536</lpage>.</citation>
</ref>
<ref id="bibr4-0003319711414867">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaughan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schoo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Janus</surname>
<given-names>ED</given-names>
</name>
<etal/>
</person-group>. <article-title>The association of levels of physical activity with metabolic syndrome in rural Australian adults</article-title>. <source>BMC Public Health</source>. <year>2009</year>;<volume>9</volume>:<fpage>273</fpage>.</citation>
</ref>
<ref id="bibr5-0003319711414867">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakka</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Laaksonen</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Physical activity in prevention and treatment of the metabolic syndrome</article-title>. <source>Appl Physiol Nutr Metabol</source>. <year>2007</year>;<volume>32</volume>(<issue>1</issue>):<fpage>76</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr6-0003319711414867">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yudkin</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Alberti</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Mclarty</surname>
<given-names>DG</given-names>
</name>
</person-group>. <article-title>Impaired glucose tolerance. Is it a risk factor for diabetes or a diagnostic ragbag?</article-title> <source>BMJ</source>. <year>1990</year>;<volume>301</volume>(<issue>6749</issue>):<fpage>397</fpage>–<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr7-0003319711414867">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meigs</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>LM</given-names>
</name>
<etal/>
</person-group>. <article-title>Using metabolic syndrome traits for efficient detection of impaired glucose tolerance</article-title>. <source>Diabetes Care</source>. <year>2004</year>;<volume>27</volume>(<issue>6</issue>):<fpage>1417</fpage>–<lpage>1426</lpage>.</citation>
</ref>
<ref id="bibr8-0003319711414867">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barr</surname>
<given-names>ELM</given-names>
</name>
<name>
<surname>Zimmet</surname>
<given-names>PZ</given-names>
</name>
<name>
<surname>Welborn</surname>
<given-names>TA</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance. The Australian diabetes, obesity, and lifestyle study (AusDiab)</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>116</volume>(<issue>2</issue>):<fpage>151</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr9-0003319711414867">
<label>9</label>
<citation citation-type="journal">
<collab collab-type="author">Third report of the National Cholesterol Education Program (NCEP)</collab>. <article-title>Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>25</issue>):<fpage>3143</fpage>–<lpage>3421</lpage>.</citation>
</ref>
<ref id="bibr10-0003319711414867">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanefeld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karasik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koehler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Westermeier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chiasson</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial</article-title>. <source>Diab Vasc Dis Res</source>. <year>2009</year>;<volume>6</volume>(<issue>1</issue>):<fpage>32</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr11-0003319711414867">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skokumas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pitsavos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Panagiotakos</surname>
<given-names>DB</given-names>
</name>
<etal/>
</person-group>. <article-title>Physical activity, high density lipoprotein cholesterol and other lipid levels in men and women from the ATTICA study</article-title>. <source>Lipids Health Dis</source>. <year>2003</year>;<volume>2</volume>:<fpage>3</fpage>.</citation>
</ref>
<ref id="bibr12-0003319711414867">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irwin</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Ainsworth</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Mayer-Davis</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Addy</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Pate</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Durstine</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Physical activity and the metabolic syndrome in a tri-ethnic sample of women</article-title>. <source>Obes Res</source>. <year>2002</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1030</fpage>–<lpage>1037</lpage>.</citation>
</ref>
<ref id="bibr13-0003319711414867">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behre</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Brohall</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hulthe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Serum adiponectin in a population sample of 64-year-old women in relation to glucose tolerance, family history of diabetes, autoimmunity, insulin sensitivity, C-peptide, and inflammation</article-title>. <source>Metabolism</source>. <year>2006</year>;<volume>55</volume>(<issue>2</issue>):<fpage>188</fpage>–<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr14-0003319711414867">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alberti</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Zimmet</surname>
<given-names>PZ</given-names>
</name>
</person-group>. <article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation</article-title>. <source>Diabet Med</source>. <year>1998</year>;<volume>15</volume>(<issue>7</issue>):<fpage>539</fpage>–<lpage>553</lpage>.</citation>
</ref>
<ref id="bibr15-0003319711414867">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bokemark</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wikstrand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wedel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>B</given-names>
</name>
</person-group>
<collab collab-type="author">Atherosclerosis and Insulin Resistances study (AIR)</collab>. <article-title>Insulin, insulin properties and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The Atherosclerosis and Insulin Resistance study (AIR)</article-title>. <source>Diabet Med</source>. <year>2002</year>;<volume>19</volume>(<issue>2</issue>):<fpage>144</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr16-0003319711414867">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brohall</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Behre</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Hulthe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wikstrand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests</article-title>. <source>Diabetes Care</source>. <year>2006</year>;<volume>29</volume>(<issue>2</issue>):<fpage>363</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr17-0003319711414867">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedewald</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Fredrickson</surname>
<given-names>DS</given-names>
</name>
</person-group>. <article-title>Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative centrifuge</article-title>. <source>Clin Chem</source>. <year>1972</year>;<volume>18</volume>(<issue>6</issue>):<fpage>499</fpage>–<lpage>502</lpage>.</citation>
</ref>
<ref id="bibr18-0003319711414867">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Aronsson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Hedblad</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gullberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wirfält</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Berglund</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Ability of physical activity measurement to assess health-related risks</article-title>. <source>Eur J Clin Nutr</source>. <year>2009</year>;<volume>63</volume>(<issue>12</issue>):<fpage>1448</fpage>–<lpage>1451</lpage>.</citation>
</ref>
<ref id="bibr19-0003319711414867">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behre</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Bergström</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>CB</given-names>
</name>
</person-group>. <article-title>Increasing leisure time physical activity is associated with less prevalence of the metabolic syndrome in healthy middle-aged men</article-title>. <source>Angiology</source>. <year>2011</year>; <comment>(accepted for publication) DOI:10.1177/0003319711398863</comment>.
</citation>
</ref>
<ref id="bibr20-0003319711414867">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinik</surname>
<given-names>AI</given-names>
</name>
</person-group>. <article-title>The metabolic basis of atherogenic dyslipidemia</article-title>. <source>Clin Cornerstone</source>. <year>2005</year>;<volume>7</volume>(<issue>2-3</issue>):<fpage>27</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr21-0003319711414867">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulló</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia-Lórda</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Megias</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Salas-Salvadó</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Systemic inflammation, adipose tissue tumour necrosis factor, and leptin expression</article-title>. <source>Obesity Res</source>. <year>2003</year>;<volume>11</volume>(<issue>4</issue>):<fpage>525</fpage>–<lpage>531</lpage>.</citation>
</ref>
<ref id="bibr22-0003319711414867">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagerberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Behre</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Wikstrand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hultén</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Hulthe</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>C- reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake, smoking and atherosclerosis</article-title>. <source>Scand J Clin Lab Invest</source>. <year>2008</year>;<volume>68</volume>(<issue>7</issue>):<fpage>534</fpage>–<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr23-0003319711414867">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sattar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gaw</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scherbakova</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study</article-title>. <source>Circulation</source>. <year>2003</year>;<volume>108</volume>(<issue>4</issue>):<fpage>414</fpage>–<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr24-0003319711414867">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Athyros</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Ganotakis</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Tziomalos</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population</article-title>. <source>Curr Med Res Opin</source>. <year>2010</year>;<volume>26</volume>(<issue>3</issue>):<fpage>713</fpage>–<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr25-0003319711414867">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niskanen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Turpeinen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Penttilä</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Uusitupa</surname>
<given-names>MI</given-names>
</name>
</person-group>. <article-title>Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis</article-title>. <source>Diabetes Care</source>. <year>1998</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1861</fpage>–<lpage>1869</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>